Carter Julian Ward

Carter Julian Ward is a declared insider of Elite Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 3 February 2011 and 26 February 2018, the trades on record add up to 12 filings.

Both buying and selling appear: 1 purchase worth €12k, against 2 sales worth €26k. The net balance comes to €14k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants.

The newest entry dates from 27 February 2018: a share grant of €24k, in Elite Pharmaceuticals Inc. The clock since the last published purchase (16 March 2011) now reads 5,717 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.